Our blog carries the voices of the people at the center of this fight: people with diabetes, advocates, and researchers pushing for insulin access and drug pricing reform worldwide. Read the latest on our campaigns, our research, and the policy fights shaping the future of essential medicines.

Content type:

All

Advocacy Stories

Interviews

News & Statements

Contains:

All

Action & Workshop

Families United for Affordable Insulin

Organizational Updates

Resource

Campaign:

All

Insulin Access

Taking on Monopoly Power

The Right to Full Care

Taking on Monopoly Power:

All

Corporate Power

Patent Reform

Public Pharma

Our Blog

• 

  June 11, 2025

  Lacy McGee

  “I Wasn’t a ‘Bad Diabetic.’ I Just Couldn’t Afford Insulin.”

• 

  February 3, 2025

  T1International

  U.S. Action 2025: Circus of Pharma Greed!

• 

  April 22, 2024

  T1International

  T1International Invited to White House Event

• 

  August 29, 2023

  Shaina Kasper, Policy & Advocacy Director, T1International

  Three Reasons Why is Insulin STILL So Expensive

• 

  May 15, 2023

  T1International

  Patient Power Shines on US Federal and Global Stages

• 

  February 20, 2023

  T1International

  T1International Patients Speak out about US Patent Process

• 

  May 14, 2020

  T1International

  Launch of U.S. State Legislative Guide for Insulin for All

• 

  January 20, 2019

  T1International

  8 Reasons Why Insulin is so Outrageously Expensive

• 

  November 1, 2018

  I-MAK

  Sanofi’s Lantus is Overpatented and Overpriced

• 

  August 26, 2016

  Elizabeth Pfiester

  Interview: Open Insulin

• 

  November 20, 2014

  John Rowley

  What’s The Deal With Generic Insulin?